(Q54484638)

30 May 2018

title

[Translational research and diagnostics in lung cancer]. (English)

1 reference

30 May 2018

author name string

F Göke

series ordinal

1

1 reference

30 May 2018

S Perner

series ordinal

2

1 reference

30 May 2018

language of work or name

German

0 references

publication date

1 November 2012

1 reference

30 May 2018

published in

Pathologe

1 reference

30 May 2018

volume

33 Suppl 2

1 reference

30 May 2018

page(s)

269-272

1 reference

30 May 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

EML4-ALK fusion lung cancer: a rare acquired event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Characterizing the cancer genome in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-012-1664-Y

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22968733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22968733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22968733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00292-012-1664-Y

1 reference

30 May 2018

1 reference

30 May 2018